Go Pro
→ Jeff Brown and Marc Chaikin's latest AI prediction explained (From Brownstone Research) (Ad)tc pixel Free VSTM Stock Alerts

Verastem (VSTM) Financials

Verastem logo
$5.54 +0.14 (+2.50%)
As of 03:24 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Verastem

Annual Income Statements for Verastem

This table shows Verastem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Consolidated Net Income / (Loss)		 -58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Net Income / (Loss) Continuing Operations		 -58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Total Pre-Tax Income 		-58 -36 -68 -72 -149 -68 -71 -74 -87 -130 -209
Total Operating Income		 -58 -37 -68 -95 -132 -49 -61 -73 -92 -115 -170
Total Gross Profit		 0.00 0.00 0.00 27 16 87 2.05 2.60 0.00 10 26
Total Revenue		 0.00 0.00 0.00 27 17 89 2.05 2.60 0.00 10 31
Operating Revenue		 - 0.00 - 27 17 89 2.05 2.60 0.00 10 31
Total Cost of Revenue		 0.00 0.00 0.00 0.17 1.24 1.77 0.00 0.00 0.00 0.00 4.60
Operating Cost of Revenue		 - 0.00 - 0.17 1.24 1.77 - - 0.00 0.00 4.60
Total Operating Expenses		 58 37 68 121 149 136 63 76 92 125 196
Selling, General & Admin Expense		 18 17 21 77 101 63 24 25 31 44 81
Research & Development Expense		 41 20 46 44 46 41 39 51 61 81 115
Amortization Expense		 - 0.00 - 0.42 1.57 0.79 - - 0.00 0.00 0.70
Total Other Income / (Expense), net		 0.33 0.56 0.00 22 -17 -18 -9.79 -0.88 4.72 -15 -39
Interest Expense		 0.00 0.00 0.56 5.81 21 17 9.97 2.14 4.14 4.56 2.96
Interest & Investment Income		 0.33 0.56 0.56 2.60 4.38 0.52 0.18 1.22 6.21 4.15 4.07
Other Income / (Expense), net		 - - - 26 -0.64 -1.31 0.00 0.05 2.64 -15 -40
Income Tax Expense		 - - - 0.00 0.00 0.19 - 0.00 0.00 0.19 0.00
Basic Earnings per Share		 ($1.61) ($0.99) ($1.76) ($1.12) ($2.00) ($0.44) ($4.90) ($4.57) ($3.96) ($3.66) ($3.02)
Weighted Average Basic Shares Outstanding		 35.93M 36.99M 38.42M 64.96M 74.58M 153.33M 14.54M 16.14M 22.05M 35.71M 69.31M
Diluted Earnings per Share		 ($1.61) ($0.99) ($1.76) ($1.37) ($2.00) ($0.44) ($4.90) ($4.57) ($3.96) ($3.66) ($3.02)
Weighted Average Diluted Shares Outstanding		 35.93M 36.99M 38.42M 69.32M 74.58M 153.33M 14.54M 16.14M 22.05M 35.71M 69.31M
Weighted Average Basic & Diluted Shares Outstanding		 35.93M 36.99M 38.50M 64.70M 148.41M 171.67M 186.33M 200.68M 25.30M 51.49M 87.84M

Quarterly Income Statements for Verastem

This table shows Verastem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -20 -27 -34 -8.26 -24 -65 -52 -26 -99 -33 -37
Consolidated Net Income / (Loss)		 -20 -27 -34 -8.26 -24 -65 -52 -26 -99 -33 -37
Net Income / (Loss) Continuing Operations		 -20 -28 -28 -8.26 -24 -71 -52 -26 -99 -33 -37
Total Pre-Tax Income 		-20 -28 0.00 0.00 0.00 -130 -52 0.00 0.00 -209 -37
Total Operating Income		 -21 -31 -28 -18 -37 -32 -44 -44 -41 -41 -45
Total Gross Profit		 0.00 - 0.00 10 0.00 - 0.00 1.82 9.57 15 16
Total Revenue		 0.00 - 0.00 10 0.00 - 0.00 2.14 11 18 19
Operating Revenue		 0.00 - - 10 0.00 - 0.00 2.14 11 - 19
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.32 1.67 2.61 2.77
Operating Cost of Revenue		 - - - 0.00 0.00 - 0.00 0.32 1.67 - 2.77
Total Operating Expenses		 21 31 28 28 37 32 44 46 50 56 61
Selling, General & Admin Expense		 7.36 8.64 10 10 12 11 15 21 21 24 22
Research & Development Expense		 14 23 18 18 25 21 29 25 29 32 38
Amortization Expense		 - - - 0.00 0.00 - 0.00 0.13 0.29 - 0.28
Total Other Income / (Expense), net		 1.12 3.44 0.21 10 13 -39 -7.89 18 -58 8.56 8.31
Interest Expense		 1.13 1.12 1.13 1.14 1.15 1.15 2.02 0.21 0.32 0.42 0.38
Interest & Investment Income		 2.25 1.87 1.37 0.98 0.83 0.97 0.96 0.82 1.18 1.10 1.30
Other Income / (Expense), net		 0.00 2.69 -0.03 10 13 -39 -6.83 17 -59 7.87 7.39
Basic Earnings per Share		 ($0.75) ($1.24) ($1.26) ($0.31) ($0.60) ($1.81) ($0.96) ($0.39) ($1.35) ($0.32) ($0.37)
Weighted Average Basic Shares Outstanding		 26.79M 22.05M 26.83M 26.86M 40.26M 35.71M 54.17M 66.14M 73.16M 69.31M 98.29M
Diluted Earnings per Share		 ($0.75) ($1.24) ($1.26) ($0.31) ($0.60) ($1.81) ($0.96) ($0.62) ($1.35) ($0.09) ($0.46)
Weighted Average Diluted Shares Outstanding		 26.79M 22.05M 26.83M 26.86M 40.26M 35.71M 54.17M 74.04M 73.16M 69.31M 99.15M
Weighted Average Basic & Diluted Shares Outstanding		 25.27M 25.30M 40.24M - 44.51M 51.49M 54.95M 61.55M 66.78M 87.84M 87.87M

Annual Cash Flow Statements for Verastem

This table details how cash moves in and out of Verastem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -9.03 7.44 50 48 -51 -11 -47 54 3.29 9.98 116
Net Cash From Operating Activities		 -46 -29 -57 -75 -139 -34 -54 -64 -86 -105 -138
Net Cash From Continuing Operating Activities		 -46 -29 -57 -75 -139 -34 -54 -64 -86 -105 -138
Net Income / (Loss) Continuing Operations		 -58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Consolidated Net Income / (Loss)		 -58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Depreciation Expense		 0.75 0.67 0.56 1.00 0.43 0.53 0.21 0.12 0.06 0.03 0.03
Amortization Expense		 0.26 -0.14 0.22 2.24 8.88 11 9.20 0.23 -1.13 -0.01 0.73
Non-Cash Adjustments To Reconcile Net Income		 10 6.29 5.03 -19 9.18 30 7.71 5.89 2.93 22 45
Changes in Operating Assets and Liabilities, net		 1.16 0.14 4.68 14 -7.80 -7.83 0.58 3.90 -0.96 3.92 26
Net Cash From Investing Activities		 -27 37 44 -138 90 -47 0.09 66 -44 60 -9.62
Net Cash From Continuing Investing Activities		 -27 37 44 -138 90 -47 0.09 66 -44 60 -9.62
Purchase of Property, Plant & Equipment		 -0.21 -0.04 - -1.51 -0.01 -0.03 -0.20 0.00 0.00 -0.03 0.00
Acquisitions		 - 0.00 - -22 - - - - 0.00 0.00 -9.62
Purchase of Investments		 -200 -82 -7.96 -125 -94 -79 -86 -18 -96 0.00 0.00
Sale and/or Maturity of Investments		 173 119 52 11 184 32 87 84 52 60 0.00
Net Cash From Financing Activities		 64 -0.01 63 261 -2.44 70 6.89 52 134 55 263
Net Cash From Continuing Financing Activities		 64 -0.01 63 261 -2.44 70 6.89 52 134 55 263
Repayment of Debt		 0.00 0.00 - 0.00 -13 -39 0.00 0.00 -0.30 -0.15 -43
Issuance of Debt		 0.00 0.00 15 155 0.57 0.00 0.00 24 15 0.00 75
Issuance of Preferred Equity		 - - - - - - 0.00 0.00 28 0.00 0.00
Issuance of Common Equity		 64 0.00 48 105 0.00 106 6.72 27 91 54 197
Other Financing Activities, net		 -0.40 -0.01 0.44 0.81 9.60 2.70 0.16 0.28 0.06 1.12 34
Cash Interest Paid		 0.00 0.00 0.30 2.11 12 5.13 1.01 1.54 3.36 3.77 6.36
Cash Income Taxes Paid		 - - - - - - - - 0.00 0.00 0.19

Quarterly Cash Flow Statements for Verastem

This table details how cash moves in and out of Verastem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -88 -18 3.52 1.02 30 -24 29 47 -27 67 -39
Net Cash From Operating Activities		 -17 -30 -28 -28 -24 -25 -39 -33 -36 -30 -52
Net Cash From Continuing Operating Activities		 -17 -30 -28 -28 -24 -25 -39 -33 -36 -30 -52
Net Income / (Loss) Continuing Operations		 -20 -27 -34 -8.26 -24 -65 -52 -26 -99 -33 -37
Consolidated Net Income / (Loss)		 -20 -27 -34 -8.26 -24 -65 -52 -26 -99 -33 -37
Depreciation Expense		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 - 0.00 0.02 0.00
Amortization Expense		 -0.37 -0.84 -0.42 0.01 0.20 0.21 0.03 0.13 0.29 0.28 0.16
Non-Cash Adjustments To Reconcile Net Income		 1.27 -1.52 7.22 -8.94 -11 35 9.12 -15 59 -7.59 -7.12
Changes in Operating Assets and Liabilities, net		 2.51 0.04 -1.25 -10 11 4.64 4.27 8.62 2.86 10 -8.57
Net Cash From Investing Activities		 -70 12 31 29 - - 0.00 - -8.28 -1.35 -16
Net Cash From Continuing Investing Activities		 -70 12 31 29 - - 0.00 - -8.28 -1.35 -16
Purchase of Investments		 -70 -13 - - - - 0.00 - - - -16
Net Cash From Financing Activities		 -0.89 -0.45 0.85 -0.41 54 0.74 67 79 18 99 29
Net Cash From Continuing Financing Activities		 -0.89 -0.45 0.85 -0.41 54 0.74 67 79 18 99 29
Repayment of Debt		 - -0.30 0.00 - - - -43 - - 0.00 0.00
Issuance of Debt		 - - 0.00 - - - 75 - - - 0.00
Issuance of Common Equity		 -0.49 - 0.00 - 14 - 30 70 - 97 0.00
Other Financing Activities, net		 -0.41 -0.15 0.85 -0.41 39 0.74 4.85 9.48 18 1.70 29

Annual Balance Sheets for Verastem

This table presents Verastem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 113 84 90 277 145 154 109 95 150 102 246
Total Current Assets		 111 81 88 253 85 145 106 93 144 95 223
Cash & Equivalents		 25 32 82 130 44 68 21 75 78 89 205
Short-Term Investments		 85 49 4.50 120 32 73 79 13 59 - 0.00
Accounts Receivable		 - - 0.00 0.31 2.52 0.24 0.52 0.03 - 0.00 8.81
Inventories, net		 - - 0.00 0.33 3.10 - - - - 0.00 1.83
Prepaid Expenses		 0.59 0.40 1.12 2.97 3.84 3.47 4.97 4.95 6.55 5.94 7.58
Other Current Assets		 - - - - - - - - 0.00 0.20 0.20
Plant, Property, & Equipment, net		 2.05 1.42 0.86 1.37 0.95 0.42 0.21 0.09 0.04 0.03 0.00
Total Noncurrent Assets		 0.20 0.92 1.14 23 59 9.00 2.71 2.09 6.00 6.55 23
Intangible Assets		 - - 0.00 22 20 - - - - 0.00 16
Other Noncurrent Operating Assets		 0.00 0.76 1.14 0.79 3.89 2.76 2.47 1.85 5.76 6.30 6.60
Other Noncurrent Nonoperating Assets		 0.20 0.16 - 0.24 35 0.24 0.24 0.24 0.24 0.24 0.24
Total Liabilities & Shareholders' Equity		 113 84 90 277 145 154 109 95 150 102 246
Total Liabilities		 11 11 32 153 138 39 21 48 71 130 189
Total Current Liabilities		 10 11 17 37 30 17 19 22 26 31 72
Short-Term Debt		 - - - 5.72 - - 0.00 - - - 0.00
Accounts Payable		 3.94 4.10 9.19 10 9.66 1.88 2.30 4.90 7.18 4.03 12
Accrued Expenses		 6.10 6.90 7.94 21 19 15 16 15 18 26 54
Other Current Liabilities		 - - - - 0.87 0.56 0.67 0.79 0.94 1.00 5.84
Total Noncurrent Liabilities		 0.52 0.34 15 116 108 22 2.51 26 45 99 117
Long-Term Debt		 - 0.00 15 115 104 19 0.25 25 40 41 76
Other Noncurrent Operating Liabilities		 0.52 0.34 0.15 1.12 4.36 2.93 2.26 1.47 4.72 59 41
Total Equity & Noncontrolling Interests		 102 72 58 124 7.17 115 88 47 57 -29 57
Total Preferred & Common Equity		 102 72 58 124 7.17 115 88 47 57 -29 57
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Total Common Equity		 102 72 58 124 7.17 115 88 47 57 -29 57
Common Stock		 301 308 361 500 532 708 751 785 882 927 1,217
Retained Earnings		 -199 -235 -303 -376 -525 -593 -664 -738 -825 -956 -1,165
Accumulated Other Comprehensive Income / (Loss)		 0.04 0.03 -0.00 0.13 0.01 0.05 0.03 0.00 0.01 0.00 5.23

Quarterly Balance Sheets for Verastem

This table presents Verastem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 176 106 126 132 196 177 228
Total Current Assets		 174 100 121 125 174 154 203
Cash & Equivalents		 95 83 113 118 164 138 166
Short-Term Investments		 71 0.00 0.00 - - - 16
Accounts Receivable		 0.00 10 - - 2.08 6.72 10
Inventories, net		 - - - - 1.17 1.79 2.29
Prepaid Expenses		 8.82 5.45 7.29 6.93 6.51 7.64 8.58
Other Current Assets		 - 0.83 0.20 0.20 0.20 0.20 0.20
Plant, Property, & Equipment, net		 0.04 0.05 0.04 0.02 0.02 0.02 0.00
Total Noncurrent Assets		 1.63 6.06 5.68 6.98 22 23 25
Intangible Assets		 - - - - 16 17 16
Other Noncurrent Operating Assets		 1.39 5.81 5.68 6.74 6.33 6.07 8.52
Other Noncurrent Nonoperating Assets		 0.24 0.24 0.00 0.24 0.00 0.00 0.24
Total Liabilities & Shareholders' Equity		 176 106 126 132 196 177 228
Total Liabilities		 72 66 94 164 160 192 146
Total Current Liabilities		 24 30 37 36 50 60 67
Short-Term Debt		 0.44 5.45 10 2.01 3.13 0.19 5.80
Accounts Payable		 5.12 6.68 4.44 7.20 8.05 9.89 9.60
Accrued Expenses		 16 17 22 25 38 45 51
Other Current Liabilities		 0.90 1.02 0.78 1.02 1.04 4.92 0.49
Total Noncurrent Liabilities		 48 35 57 129 110 133 79
Long-Term Debt		 40 35 31 71 74 78 73
Other Noncurrent Operating Liabilities		 8.09 0.00 26 57 36 55 6.07
Total Equity & Noncontrolling Interests		 83 19 11 -32 36 -16 82
Total Preferred & Common Equity		 83 19 11 -32 36 -16 82
Preferred Stock		 - - 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 83 19 11 -32 36 -16 82
Common Stock		 881 886 902 969 1,064 1,114 1,275
Retained Earnings		 -798 -867 -891 -1,008 -1,034 -1,132 -1,202
Accumulated Other Comprehensive Income / (Loss)		 0.05 0.00 0.00 6.64 5.29 2.55 8.62

Annual Metrics And Ratios for Verastem

This table displays calculated financial ratios and metrics derived from Verastem's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 36,934,804.00 36,992,418.00 40,489,396.00 73,740,167.00 74,349,659.00 169,774,432.00 182,185,991.00 210,090,850.00 25,267,436.00 - 66,776,006.00
DEI Adjusted Shares Outstanding		 3,077,900.00 3,082,702.00 3,374,116.00 6,145,014.00 6,195,805.00 14,147,869.00 15,182,166.00 17,507,571.00 25,267,436.00 - 66,776,006.00
DEI Earnings Per Adjusted Shares Outstanding		 -18.80 -11.82 -20.09 -11.79 -24.08 -4.79 -4.69 -4.22 -3.46 - -3.14
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% -34.67% 407.08% -97.68% 26.45% -100.00% 0.00% 209.14%
EBITDA Growth		 -8.11% 36.22% -83.77% 1.54% -87.40% 68.38% -33.01% -39.49% -24.77% -43.65% -61.38%
EBIT Growth		 -8.57% 36.42% -83.24% -2.10% -92.10% 61.89% -21.19% -18.70% -22.71% -45.39% -61.93%
NOPAT Growth		 -8.57% 36.42% -83.24% -39.79% -39.63% 62.70% -24.41% -18.77% -26.25% -24.84% -47.99%
Net Income Growth		 -8.43% 37.03% -86.06% -6.83% -105.99% 54.61% -5.13% -3.67% -18.36% -49.53% -60.35%
EPS Growth		 22.22% 38.51% -77.78% 22.16% -45.99% 78.00% -5.13% -3.67% 13.35% 7.58% 17.49%
Operating Cash Flow Growth		 -23.46% 35.28% -94.38% -30.02% -85.89% 75.81% -59.68% -19.01% -35.79% -21.18% -31.25%
Free Cash Flow Firm Growth		 7.18% 31.82% -67.38% -79.17% -29.81% 78.16% -103.30% -10.06% -28.97% 64.33% -467.73%
Invested Capital Growth		 -94.36% -9.63% -61.61% 63.69% 100.97% -26,374.00% 3.41% -25.64% -17.61% -311.86% 7.46%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 4.74% 15.99% -3.40% 103.67% -37.40% 0.00% 0.00% 131.06%
EBITDA Q/Q Growth		 3.43% 0.21% -10.24% 14.45% 1.25% 24.39% -0.63% -0.33% -15.83% 0.00% 14.88%
EBIT Q/Q Growth		 3.38% 0.43% -10.16% 11.90% 0.25% 23.10% 0.39% -0.47% -14.83% 0.00% 14.81%
NOPAT Q/Q Growth		 3.38% 0.43% -10.16% -20.63% 0.73% 25.10% 0.39% -0.46% -18.37% 0.00% -6.17%
Net Income Q/Q Growth		 3.48% 0.57% -10.75% 8.68% -22.52% 21.83% 4.54% -0.45% -13.75% 0.00% 13.12%
EPS Q/Q Growth		 12.02% -2.06% -6.67% 4.86% -6.95% 13.73% 4.54% -0.45% -37.98% 0.00% 8.48%
Operating Cash Flow Q/Q Growth		 -6.90% 12.60% -33.48% 1.51% -14.97% 31.65% 18.03% -11.73% -17.80% 4.19% -3.66%
Free Cash Flow Firm Q/Q Growth		 4.47% 15.76% -37.52% -27.95% 5.88% 27.10% 20.74% -14.08% -23.50% 0.00% -60.99%
Invested Capital Q/Q Growth		 5.16% -90.15% 17.22% 61.06% 101.94% 32.29% -63.54% 4.40% 11.60% 0.00% 4.61%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 99.38% 92.91% 98.01% 100.00% 100.00% 0.00% 100.00% 85.12%
EBITDA Margin		 0.00% 0.00% 0.00% -247.00% -708.48% -44.17% -2,533.17% -2,794.45% 0.00% -1,300.18% -678.72%
Operating Margin		 0.00% 0.00% 0.00% -354.75% -758.14% -55.76% -2,991.18% -2,809.59% 0.00% -1,149.56% -550.33%
EBIT Margin		 0.00% 0.00% 0.00% -259.10% -761.81% -57.25% -2,991.18% -2,807.78% 0.00% -1,300.39% -681.16%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% -271.11% -854.77% -76.51% -3,468.10% -2,843.30% 0.00% -1,306.37% -677.59%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.29% 100.00% 100.00% 100.00% 100.14% 100.00%
Interest Burden Percent		 99.43% 98.48% 100.00% 104.63% 112.20% 133.27% 115.94% 101.26% 97.68% 100.32% 99.48%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -60.52% -41.70% -104.33% -79.61% -226.98% -110.62% -70.21% -109.39% -138.76% -526.34% -1,480.15%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% -195,661.40% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% -37.72% -62.98% -33.85% -46.70% -71.56% 0.00% -103.51% -121.03%
Return on Assets (ROA)		 0.00% 0.00% 0.00% -39.47% -70.67% -45.24% -54.14% -72.47% 0.00% -103.99% -120.39%
Return on Common Equity (ROCE)		 -60.52% -41.70% -104.33% -79.61% -226.98% -110.62% -70.21% -109.39% -115.45% -301.99% -1,480.15%
Return on Equity Simple (ROE_SIMPLE)		 -56.47% -50.40% -117.54% -58.27% -2,079.86% -58.75% -81.32% -155.75% 0.00% 452.14% 0.00%
Net Operating Profit after Tax (NOPAT)		 -41 -26 -47 -66 -93 -35 -43 -51 -64 -80 -119
NOPAT Margin		 0.00% 0.00% 0.00% -248.33% -530.70% -39.03% -2,093.83% -1,966.71% 0.00% -804.69% -385.23%
Net Nonoperating Expense Percent (NNEP)		 -16.84% -11.01% -26.60% -6.05% -82.85% -48.95% -24.68% -27.82% -28.53% -68.90% -102.13%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -70.99% -66.14% -680.16% -89.19%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.62% 7.09% 1.99% 0.00% 0.00% 0.00% 0.00% 14.88%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 289.19% 579.81% 70.90% 1,174.62% 962.06% 0.00% 436.22% 262.49%
R&D to Revenue		 0.00% 0.00% 0.00% 163.37% 262.25% 46.74% 1,916.56% 1,947.53% 0.00% 813.34% 370.70%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 454.14% 851.05% 153.77% 3,091.18% 2,909.59% 0.00% 1,249.56% 635.45%
Earnings before Interest and Taxes (EBIT)		 -58 -37 -68 -69 -133 -51 -61 -73 -89 -130 -211
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -57 -36 -67 -66 -124 -39 -52 -73 -91 -130 -210
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.67 0.57 2.15 1.99 13.89 3.14 4.27 1.78 3.58 0.00 9.01
Price to Tangible Book Value (P/TBV)		 0.67 0.57 2.15 2.41 0.00 3.14 4.27 1.78 3.58 0.00 12.64
Price to Revenue (P/Rev)		 0.00 0.00 0.00 9.27 5.71 4.09 181.92 32.57 0.00 23.01 16.68
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 2,554.91 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 4.44 7.32 2.64 133.21 8.16 0.00 18.20 12.51
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.26 0.97 14.44 0.17 0.00 0.52 0.51 -1.41 1.33
Long-Term Debt to Equity		 0.00 0.00 0.26 0.92 14.44 0.17 0.00 0.52 0.51 -1.41 1.33
Financial Leverage		 -1.06 -1.10 -1.18 -1.11 -1.04 -1.11 -1.13 -1.21 -1.28 -2.93 -6.25
Leverage Ratio		 1.11 1.13 1.33 2.02 3.21 2.45 1.30 1.51 1.94 5.06 12.29
Compound Leverage Factor		 1.10 1.11 1.33 2.11 3.60 3.26 1.50 1.53 1.90 5.08 12.23
Debt to Total Capital		 0.00% 0.00% 20.45% 49.21% 93.53% 14.18% 0.28% 34.10% 33.79% 344.21% 57.16%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 2.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 20.45% 46.88% 93.53% 14.18% 0.28% 34.10% 33.79% 344.21% 57.16%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.84% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 79.55% 50.79% 6.47% 85.82% 99.72% 65.90% 48.37% -244.21% 42.84%
Debt to EBITDA		 0.00 0.00 -0.22 -1.83 -0.84 -0.49 0.00 -0.34 -0.44 -0.31 -0.36
Net Debt to EBITDA		 0.00 0.00 1.07 1.96 -0.23 3.28 1.92 0.87 1.07 0.37 0.61
Long-Term Debt to EBITDA		 0.00 0.00 -0.22 -1.74 -0.84 -0.49 0.00 -0.34 -0.44 -0.31 -0.36
Debt to NOPAT		 0.00 0.00 -0.31 -1.82 -1.12 -0.55 -0.01 -0.48 -0.62 -0.51 -0.64
Net Debt to NOPAT		 0.00 0.00 1.51 1.95 -0.30 3.71 2.33 1.24 1.51 0.60 1.08
Long-Term Debt to NOPAT		 0.00 0.00 -0.31 -1.73 -1.12 -0.55 -0.01 -0.48 -0.62 -0.51 -0.64
Altman Z-Score		 0.79 -2.20 -3.95 -0.72 -7.08 0.66 1.18 -11.40 -7.01 -15.49 -6.94
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.80% 42.62% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 10.96 7.40 5.13 6.83 2.84 8.48 5.69 4.29 5.45 3.07 3.09
Quick Ratio		 10.91 7.36 5.06 6.74 2.61 8.28 5.42 4.06 5.20 2.87 2.96
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -37 -25 -42 -75 -98 -21 -43 -48 -62 -22 -125
Operating Cash Flow to CapEx		 -21,591.94% -75,600.00% 0.00% -5,229.12% -1,978,828.57% -101,533.33% -27,296.94% 0.00% 0.00% -374,182.14% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -75.25 -12.97 -4.75 -1.23 -4.36 -22.37 -14.90 -4.82 -42.12
Operating Cash Flow to Interest Expense		 0.00 0.00 -102.52 -12.83 -6.72 -1.93 -5.37 -29.80 -20.89 -22.97 -46.39
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -102.52 -13.07 -6.72 -1.93 -5.38 -29.80 -20.89 -22.97 -46.39
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.15 0.08 0.59 0.02 0.03 0.00 0.08 0.18
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 12.34 64.07 5.44 9.49 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.72 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 23.96 15.07 129.88 6.56 17.19 0.00 289.86 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.02 0.12 0.31 0.00 0.00 0.00 0.00 0.56
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 29.59 5.70 67.12 38.45 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 504.60 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 21,500.71 2,934.74 1,192.20 0.00 0.00 0.00 0.00 653.59
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 -21,500.71 -2,400.55 -1,186.50 67.12 38.45 0.00 0.00 -653.59
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -7.99 -8.76 -14 -5.14 0.05 -13 -13 -16 -19 -77 -71
Invested Capital Turnover		 0.00 0.00 0.00 -2.77 -6.86 -13.53 -0.16 -0.18 0.00 -0.21 -0.42
Increase / (Decrease) in Invested Capital		 -3.88 -0.77 -5.40 9.02 5.19 -13 0.45 -3.25 -2.81 -58 5.77
Enterprise Value (EV)		 -42 -39 52 119 128 233 273 21 130 182 387
Market Capitalization		 69 41 124 248 100 362 373 85 206 230 516
Book Value per Share		 $2.77 $1.95 $1.42 $1.69 $0.10 $0.68 $0.48 $0.23 $2.27 ($0.65) $0.86
Tangible Book Value per Share		 $2.77 $1.95 $1.42 $1.39 ($0.17) $0.68 $0.48 $0.23 $2.27 ($0.65) $0.61
Total Capital		 102 72 73 245 111 134 88 72 119 12 134
Total Debt		 0.00 0.00 15 120 104 19 0.25 25 40 41 76
Total Long-Term Debt		 0.00 0.00 15 115 104 19 0.25 25 40 41 76
Net Debt		 -110 -81 -72 -129 28 -128 -100 -63 -97 -48 -129
Capital Expenditures (CapEx)		 0.21 0.04 0.00 1.43 0.01 0.03 0.20 0.00 0.00 0.03 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -9.52 -11 -16 -28 -20 -13 -13 -17 -20 -25 -54
Debt-free Net Working Capital (DFNWC)		 101 70 71 222 55 128 87 71 117 64 151
Net Working Capital (NWC)		 101 70 71 216 55 128 87 71 117 64 151
Net Nonoperating Expense (NNE)		 17 11 20 6.09 57 33 28 23 23 50 90
Net Nonoperating Obligations (NNO)		 -110 -81 -72 -129 -7.12 -128 -100 -63 -97 -48 -129
Total Depreciation and Amortization (D&A)		 1.02 0.53 0.78 3.23 9.31 12 9.40 0.35 -1.07 0.02 0.76
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% -103.88% -117.07% -15.12% -638.38% -642.80% 0.00% -248.30% -174.18%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 830.52% 315.48% 144.43% 4,245.01% 2,742.95% 0.00% 639.88% 488.92%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 809.12% 315.48% 144.43% 4,245.01% 2,742.95% 0.00% 639.88% 488.92%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($19.32) ($11.88) ($21.12) ($13.44) ($24.00) $0.00 ($4.92) ($4.56) ($3.96) ($3.66) ($3.02)
Adjusted Weighted Average Basic Shares Outstanding		 3.08M 3.08M 4.23M 5.41M 6.21M 0.00 14.53M 16.14M 22.05M 35.71M 69.31M
Adjusted Diluted Earnings per Share		 ($19.32) ($11.88) ($21.12) ($16.44) ($24.00) $0.00 ($4.92) ($4.56) ($3.93) ($3.66) ($3.02)
Adjusted Weighted Average Diluted Shares Outstanding		 3.08M 3.08M 4.23M 5.78M 6.21M 0.00 14.53M 16.14M 22.05M 35.71M 69.31M
Adjusted Basic & Diluted Earnings per Share		 ($19.32) ($11.88) ($21.12) ($13.44) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 2.99M 3.08M 3.20M 6.16M 12.37M 0.00 15.53M 16.72M 25.30M 51.49M 87.84M
Normalized Net Operating Profit after Tax (NOPAT)		 -41 -26 -47 -66 -93 -35 -43 -51 -64 -80 -119
Normalized NOPAT Margin		 0.00% 0.00% 0.00% -248.33% -530.70% -39.03% -2,093.83% -1,966.71% 0.00% -804.69% -385.23%
Pre Tax Income Margin		 0.00% 0.00% 0.00% -271.11% -854.77% -76.29% -3,468.10% -2,843.30% 0.00% -1,304.52% -677.59%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 -121.30 -11.92 -6.45 -2.92 -6.16 -34.11 -21.61 -28.50 -71.04
NOPAT to Interest Expense		 0.00 0.00 -84.91 -11.42 -4.50 -1.99 -4.31 -23.89 -15.57 -17.64 -40.18
EBIT Less CapEx to Interest Expense		 0.00 0.00 -121.30 -12.16 -6.45 -2.92 -6.18 -34.11 -21.61 -28.51 -71.04
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -84.91 -11.66 -4.50 -1.99 -4.33 -23.89 -15.57 -17.65 -40.18
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Verastem

This table displays calculated financial ratios and metrics derived from Verastem's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 25,250,711.00 25,267,436.00 25,295,495.00 25,325,551.00 40,243,745.00 44,506,526.00 51,486,705.00 54,949,170.00 61,545,270.00 66,776,006.00 87,835,106.00
DEI Adjusted Shares Outstanding		 25,250,711.00 25,267,436.00 25,295,495.00 25,325,551.00 40,243,745.00 44,506,526.00 51,486,705.00 54,949,170.00 61,545,270.00 66,776,006.00 87,835,106.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.79 -1.08 -1.34 -0.33 -0.60 -1.45 -1.01 -0.47 -1.60 -0.49 -0.42
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -78.63% 0.00% 0.00% 0.00%
EBITDA Growth		 -23.29% -75.19% -46.93% 59.87% -8.15% -139.00% -78.81% -226.58% -322.70% 52.41% 26.72%
EBIT Growth		 -20.46% -68.81% -45.16% 60.16% -10.99% -146.75% -81.58% -227.66% -320.22% 52.13% 26.47%
NOPAT Growth		 -20.33% -84.85% -45.05% 9.93% -73.78% -1.45% -57.43% -139.45% -9.95% -31.29% -1.64%
Net Income Growth		 -10.58% -62.83% -115.50% 66.00% -19.81% -135.86% -53.86% -214.12% -311.06% 49.01% 29.77%
EPS Growth		 0.00% -19.23% -1,475.00% 77.37% 20.00% -45.97% 23.81% -100.00% -125.00% 95.03% 52.08%
Operating Cash Flow Growth		 -9.99% -78.63% -39.54% -38.51% -43.44% 15.44% -36.63% -18.47% -52.20% -19.34% -34.75%
Free Cash Flow Firm Growth		 -198.49% -122.40% -413.95% -216.45% 34.25% 291.50% 229.42% 161.73% 189.56% -195.69% -301.87%
Invested Capital Growth		 -27.19% -17.61% 83.17% 0.00% -90.02% -311.86% -2,681.05% 0.00% -85.88% 7.46% 72.35%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -100.00% 0.00% 0.00% 0.00% 426.06% 55.98% 6.48%
EBITDA Q/Q Growth		 -7.53% -35.10% 2.66% 71.62% -189.80% -198.55% 27.18% 48.21% -275.10% 66.39% -12.13%
EBIT Q/Q Growth		 -4.81% -33.51% 1.27% 71.16% -191.94% -196.82% 27.34% 48.00% -274.40% 66.19% -11.61%
NOPAT Q/Q Growth		 -5.01% -46.13% 9.89% 34.86% -102.60% 14.69% -39.84% 0.93% 6.97% -1.87% -8.25%
Net Income Q/Q Growth		 17.61% -36.81% -23.73% 75.62% -190.30% -169.33% 19.28% 50.23% -279.88% 66.59% -11.16%
EPS Q/Q Growth		 45.26% -65.33% -1.61% 75.40% -93.55% -201.67% 46.96% 35.42% -117.74% 93.33% -411.11%
Operating Cash Flow Q/Q Growth		 16.65% -78.92% 4.63% 2.60% 13.69% -5.48% -54.09% 15.55% -10.88% 17.29% -73.99%
Free Cash Flow Firm Q/Q Growth		 -0.28% -82.90% -75.27% 1.56% 79.17% 632.73% 18.46% -53.05% -69.77% -669.20% -149.89%
Invested Capital Q/Q Growth		 -6.22% 11.60% 85.28% 100.00% 0.00% -91.60% 0.61% 33.74% -47.31% 4.61% 70.30%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 100.00% 0.00% 0.00% 0.00% 85.12% 85.15% 85.10% 85.15%
EBITDA Margin		 0.00% 0.00% 0.00% -80.89% 0.00% 0.00% 0.00% -1,236.17% -881.42% -189.95% -200.02%
Operating Margin		 0.00% 0.00% 0.00% -182.77% 0.00% 0.00% 0.00% -2,047.92% -362.17% -236.53% -240.46%
EBIT Margin		 0.00% 0.00% 0.00% -81.01% 0.00% 0.00% 0.00% -1,242.12% -884.02% -191.65% -200.88%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% -82.56% 0.00% 0.00% 0.00% -1,213.57% -876.34% -187.72% -195.98%
Tax Burden Percent		 99.07% 98.80% 0.00% 0.00% 0.00% 49.48% 100.08% 0.00% 0.00% 15.71% 100.00%
Interest Burden Percent		 94.75% 97.37% 0.00% 0.00% 0.00% 185.83% 102.07% 0.00% 0.00% 623.33% 97.56%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -91.87% -138.76% -224.04% 0.00% -136.87% -526.34% -3,929.71% -461.93% -2,888.71% -1,480.15% -786.15%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -13.52% -78.01% -34.05% -55.41%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -13.21% -77.33% -33.35% -54.06%
Return on Common Equity (ROCE)		 -80.24% -115.45% -123.39% 0.00% -94.46% -301.99% 7,044.12% -461.93% 772.84% -1,480.15% -786.15%
Return on Equity Simple (ROE_SIMPLE)		 -92.34% 0.00% -559.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -15 -22 -20 -13 -26 -22 -31 -31 -29 -29 -31
NOPAT Margin		 0.00% 0.00% 0.00% -127.94% 0.00% 0.00% 0.00% -1,433.54% -253.52% -165.57% -168.32%
Net Nonoperating Expense Percent (NNEP)		 -4.96% -6.94% -25.09% 0.00% 1.97% -58.29% -48.64% 10.82% -106.15% -4.39% -7.01%
Return On Investment Capital (ROIC_SIMPLE)		 - -22.37% -32.90% - -50.13% -186.91% -75.32% -27.00% -45.39% -21.74% -19.56%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 14.88% 14.86% 14.90% 14.85%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 102.15% 0.00% 0.00% 0.00% 967.20% 186.87% 139.42% 119.43%
R&D to Revenue		 0.00% 0.00% 0.00% 180.62% 0.00% 0.00% 0.00% 1,159.85% 257.86% 180.62% 204.69%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 282.77% 0.00% 0.00% 0.00% 2,133.04% 447.31% 321.64% 325.62%
Earnings before Interest and Taxes (EBIT)		 -21 -28 -28 -8.10 -24 -70 -51 -27 -99 -34 -38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -22 -29 -29 -8.09 -23 -70 -51 -26 -99 -33 -37
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.47 3.58 15.83 0.00 10.88 0.00 0.00 6.32 0.00 9.01 5.69
Price to Tangible Book Value (P/TBV)		 2.47 3.58 15.83 0.00 10.88 0.00 0.00 11.17 0.00 12.64 7.09
Price to Revenue (P/Rev)		 0.00 0.00 0.00 7.55 12.03 23.01 31.05 106.71 40.62 16.68 9.39
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 6.90 18.20 26.64 66.04 36.18 12.51 7.32
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.39 0.51 1.02 0.00 1.26 -1.41 -2.27 2.15 -5.04 1.33 0.97
Long-Term Debt to Equity		 0.38 0.51 0.88 0.00 0.95 -1.41 -2.20 2.06 -5.03 1.33 0.89
Financial Leverage		 -1.23 -1.28 -1.20 0.00 -1.45 -2.93 -11.49 -2.41 -7.90 -6.25 -2.99
Leverage Ratio		 1.72 1.94 2.41 0.00 2.22 5.06 31.34 5.44 18.17 12.29 7.29
Compound Leverage Factor		 1.63 1.89 0.00 0.00 0.00 9.41 31.99 0.00 0.00 76.63 7.11
Debt to Total Capital		 27.89% 33.79% 50.51% 0.00% 55.79% 344.21% 179.00% 68.22% 124.73% 57.16% 49.11%
Short-Term Debt to Total Capital		 0.31% 0.00% 6.74% 0.00% 13.73% 0.00% 4.90% 2.76% 0.30% 0.00% 3.61%
Long-Term Debt to Total Capital		 27.58% 33.79% 43.77% 0.00% 42.06% 344.21% 174.11% 65.46% 124.43% 57.16% 45.50%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 14.62% 17.84% 26.17% 0.00% 29.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 57.49% 48.37% 23.32% 0.00% 15.18% -244.21% -79.00% 31.78% -24.73% 42.84% 50.89%
Debt to EBITDA		 -0.52 -0.44 -0.41 0.00 -0.46 -0.31 -0.48 -0.45 -0.32 -0.36 -0.40
Net Debt to EBITDA		 1.60 1.07 0.43 0.00 0.81 0.37 0.29 0.51 0.24 0.61 0.52
Long-Term Debt to EBITDA		 -0.51 -0.44 -0.36 0.00 -0.34 -0.31 -0.47 -0.43 -0.32 -0.36 -0.37
Debt to NOPAT		 -0.74 -0.62 -0.58 0.00 -0.51 -0.51 -0.80 -0.71 -0.70 -0.64 -0.66
Net Debt to NOPAT		 2.30 1.51 0.60 0.00 0.90 0.60 0.48 0.79 0.53 1.08 0.86
Long-Term Debt to NOPAT		 -0.73 -0.62 -0.50 0.00 -0.38 -0.51 -0.78 -0.68 -0.70 -0.64 -0.61
Altman Z-Score		 -4.00 -5.67 -8.84 0.00 -8.85 -13.54 -9.97 -6.20 -8.41 -4.57 -5.08
Noncontrolling Interest Sharing Ratio		 12.65% 16.80% 44.93% 0.00% 30.99% 42.62% 279.25% 0.00% 126.75% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.33 5.45 3.28 0.00 3.23 3.07 3.50 3.46 2.58 3.09 3.04
Quick Ratio		 6.96 5.20 3.08 0.00 3.03 2.87 3.30 3.30 2.42 2.96 2.87
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -10 -19 -33 -33 -6.83 36 43 20 6.11 -35 -87
Operating Cash Flow to CapEx		 0.00% 0.00% -134,795.24% -393,857.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -9.20 -16.95 -29.45 -28.79 -5.95 31.73 21.35 95.39 19.16 -83.85 -227.64
Operating Cash Flow to Interest Expense		 -14.69 -26.50 -25.05 -24.23 -20.73 -21.90 -19.17 -154.07 -113.53 -72.18 -136.43
Operating Cash Flow Less CapEx to Interest Expense		 -14.69 -26.50 -25.07 -24.23 -20.73 -21.90 -19.17 -154.07 -113.53 -72.18 -136.43
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.07 0.08 0.08 0.01 0.09 0.18 0.28
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.03 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 270.27 289.86 294.12 101.76 453.53 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.28 0.56 0.88
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 354.58 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,340.63 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9,236.34 1,315.14 653.59 415.92
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -7,541.13 -1,315.14 -653.59 -415.92
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -21 -19 -2.76 0.00 -40 -77 -77 -51 -75 -71 -21
Invested Capital Turnover		 0.00 0.00 0.00 0.00 -0.33 -0.21 -0.25 -0.08 -0.23 -0.42 -1.01
Increase / (Decrease) in Invested Capital		 -4.53 -2.81 14 20 -19 -58 -74 -51 -35 5.77 56
Enterprise Value (EV)		 101 130 277 0.00 69 182 266 141 484 387 363
Market Capitalization		 205 206 298 75 120 230 310 228 543 516 466
Book Value per Share		 $3.29 $2.27 $0.75 $0.00 $0.27 ($0.65) ($0.63) $0.66 ($0.25) $0.86 $0.93
Tangible Book Value per Share		 $3.29 $2.27 $0.75 $0.00 $0.27 ($0.65) ($0.63) $0.37 ($0.52) $0.61 $0.75
Total Capital		 145 119 81 0.00 73 12 41 113 63 134 161
Total Debt		 40 40 41 0.00 41 41 73 77 78 76 79
Total Long-Term Debt		 40 40 35 0.00 31 41 71 74 78 76 73
Net Debt		 -125 -97 -43 0.00 -73 -48 -44 -87 -59 -129 -103
Capital Expenditures (CapEx)		 0.00 0.00 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -15 -20 -8.62 0.00 -20 -25 -26 -37 -43 -54 -40
Debt-free Net Working Capital (DFNWC)		 151 117 75 0.00 93 64 91 127 95 151 142
Net Working Capital (NWC)		 151 117 69 0.00 83 64 89 124 94 151 136
Net Nonoperating Expense (NNE)		 5.09 5.57 14 -4.54 -1.95 42 21 -4.70 70 3.88 5.16
Net Nonoperating Obligations (NNO)		 -126 -97 -43 0.00 -73 -48 -44 -87 -59 -129 -103
Total Depreciation and Amortization (D&A)		 -0.37 -0.83 -0.41 0.01 0.21 0.21 0.04 0.13 0.29 0.30 0.16
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% -198.84% -248.30% -264.79% -1,744.31% -322.70% -174.18% -80.31%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 932.91% 639.88% 910.90% 5,945.06% 706.57% 488.92% 286.08%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 832.88% 639.88% 890.80% 5,798.41% 705.16% 488.92% 274.40%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.75) ($1.24) $0.00 $0.00 ($0.60) ($1.81) ($0.96) ($0.39) ($1.35) ($0.32) ($0.37)
Adjusted Weighted Average Basic Shares Outstanding		 26.79M 22.05M 0.00 0.00 40.26M 35.71M 54.17M 66.14M 73.16M 69.31M 98.29M
Adjusted Diluted Earnings per Share		 $0.00 ($1.24) $0.00 $0.00 ($0.60) ($1.81) ($0.96) ($0.62) ($1.35) ($0.09) ($0.46)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 22.05M 0.00 0.00 40.26M 35.71M 54.17M 74.04M 73.16M 69.31M 99.15M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($1.24) $0.00 $0.00 $0.00 ($1.81) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.27M 25.30M 0.00 0.00 44.51M 51.49M 54.95M 61.55M 66.78M 87.84M 87.87M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -22 -20 -13 -26 -22 -31 -31 -29 -29 -31
Normalized NOPAT Margin		 0.00% 0.00% 0.00% -127.94% 0.00% 0.00% 0.00% -1,433.54% -253.52% -165.57% -168.32%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,194.59% -195.98%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -18.87 -25.40 -24.86 -7.12 -20.60 -61.26 -25.28 -125.21 -311.54 -80.98 -98.18
NOPAT to Interest Expense		 -13.21 -19.46 -17.38 -11.24 -22.58 -19.30 -15.32 -144.50 -89.34 -69.96 -82.27
EBIT Less CapEx to Interest Expense		 -18.87 -25.40 -24.88 -7.12 -20.60 -61.26 -25.28 -125.21 -311.54 -80.98 -98.18
NOPAT Less CapEx to Interest Expense		 -13.21 -19.46 -17.40 -11.25 -22.58 -19.30 -15.32 -144.50 -89.34 -69.96 -82.27
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Verastem’s latest quarter shows a company with improving revenue, but still deep operating losses and heavy reliance on financing to stay funded. In Q1 2026, revenue rose to $18.7 million, up from $17.5 million in Q4 2025 and far above the $0 revenue level seen in early 2024. However, operating expenses remain much larger than revenue, which led to a $36.6 million net loss in the quarter. The balance sheet is still supported by a sizable cash position, but cash declined during the quarter as operations and investing consumed more than financing provided.

  • Revenue continues to scale: Q1 2026 revenue was $18.7 million, up from $17.5 million in Q4 2025 and well above the company’s earlier-stage 2024 run rate.
  • Gross profit remains healthy: Gross profit came in at $15.9 million in Q1 2026, showing the business can generate meaningful margin before operating expenses.
  • Cash position is still strong: Verastem ended Q1 2026 with $165.6 million in cash and equivalents, plus $16.1 million in short-term investments.
  • Equity improved versus last year: Total common equity was $81.8 million in Q1 2026, up from a negative $32.4 million in Q1 2025 and a negative $15.5 million in Q3 2025.
  • Losses narrowed dramatically versus the prior year: Q1 2026 net loss of $36.6 million was an improvement from the $52.1 million loss in Q1 2025.
  • Interest and other income helped offset operating losses: Q1 2026 had $8.3 million of total other income, which reduced the impact of the operating loss, though not enough to reach profitability.
  • Shares outstanding remain elevated: Weighted average diluted shares were 99.1 million in Q1 2026, which can limit per-share earnings power if losses continue.
  • Debt remains meaningful: The company reported $5.8 million of short-term debt and $73.1 million of long-term debt at the end of Q1 2026.
  • Q1 cash burn was significant but manageable for now: Net cash used in operating activities was $52.1 million, partly offset by $28.7 million in financing inflows.
  • Operating losses are still very large: Q1 2026 operating loss was $44.9 million, compared with revenue of only $18.7 million.
  • Research and development spending remains high: R&D expense was $38.2 million in Q1 2026, a major driver of the quarterly loss.
  • Cash declined quarter over quarter: Cash and equivalents fell from $137.7 million at Q3 2025 to $165.6 million at Q1 2026, but total cash plus investments still fell by $39.4 million in the quarter.
  • Operating cash flow remains negative: Verastem used $52.1 million in operating cash in Q1 2026, underscoring that the business is not self-funding yet.
  • Quarterly financing support was limited: Unlike Q4 2025, when common equity issuance helped drive $98.6 million of financing cash, Q1 2026 financing cash mainly came from “other financing activities,” not core recurring financing sources.

Bottom line: Verastem is showing encouraging top-line growth and improving balance-sheet strength compared with 2024, but it remains a pre-profitability biotech with substantial losses and ongoing cash burn. Investors will likely focus on whether revenue can keep growing fast enough to eventually outpace operating costs, while also watching for any need to raise additional capital.

07/10/26 03:24 PM ETAI Generated. May Contain Errors.

Verastem Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Verastem's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Verastem's net income appears to be on an upward trend, with a most recent value of -$209.47 million in 2025, rising from -$57.87 million in 2015. The previous period was -$130.64 million in 2024. Check out Verastem's forecast to explore projected trends and price targets.

Verastem's total operating income in 2025 was -$170.13 million, based on the following breakdown:
  • Total Gross Profit: $26.31 million
  • Total Operating Expenses: $196.44 million

Over the last 10 years, Verastem's total revenue changed from $0.00 in 2015 to $30.91 million in 2025, a change of 3,091,400,000.0%.

Verastem's total liabilities were at $189.25 million at the end of 2025, a 45.1% increase from 2024, and a 1,681.1% increase since 2015.

In the past 10 years, Verastem's cash and equivalents has ranged from $21.25 million in 2021 to $204.99 million in 2025, and is currently $204.99 million as of their latest financial filing in 2025.

Over the last 10 years, Verastem's book value per share changed from 2.77 in 2015 to 0.86 in 2025, a change of -69.1%.


Related Companies

Financial statements for NASDAQ:VSTM last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
A Uranium Major Just Became One of Our Largest Shareholders
IsoEnergy is acquiring the Dieter Lake uranium project in Quebec - but it's not taking cash. Instead, IsoEnerg...
The Tomorrow Investor | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Jeff Brown and Marc Chaikin's latest AI prediction explained
Jeff Brown and Marc Chaikin - the duo who identified Nvidia a decade ago - are forecasting that Elon Musk's AI...
Brownstone Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel